Dowden Nathan J (CIK 1873392) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-11). Recent activity: Sell TRDA (3,116 shares), Sell TRDA (11,894 shares), Buy TRDA (55,800 shares), Sell TRDA (7,223 shares), Sell TRDA (14,038 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 3,116 | $40,570 |
| 2026-03-11 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 11,894 | $155,217 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Buy | 55,800 | $0 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 7,223 | $84,220 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 14,038 | $165,087 |
| 2025-09-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 1,746 | $9,481 |
| 2025-03-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Buy | 60,800 | $0 |
| 2025-03-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 5,144 | $60,082 |
Source: SEC Form 4 filings · as of 2026-03-11